Abstract
Human breast cancer cell lines are required asmodels for use in the understanding of breastcarcinoma, and for improving the ability of cellscreens to detect appropriate anti-cancer agents. Four humanbreast cancer cell lines (MT-1, MaTu, MT-3 andMC4000) were established from human tumour xenografts grownin nude mice. All the lines were shownto be of human origin by karyotype analysis,were epithelial in morphology by both light andelectron microscopy, were positive for cytokeratin 18, andwere free from mycoplasma, bacterial, yeast and fungalcontamination. All of the new lines were shownto be ER and PgR negative, while usingthe same procedures (i.e. radioligand binding and immunohistochemicalstaining) the positive control cell line MCF-7 wasshown to be positive. MaTu had been previouslyreported as ER and PgR positive in vivoand it may be that this characteristic hadbeen lost due to in vitro selection pressures.The growth rates of all the new breastcancer cell lines were similar and within thelimits required for incorporation into a panel forscreening anticancer drugs by a microtetrazolium based, colorimetricgrowth inhibition assay. Three of the lines (MT-1,MaTu and MC4000) were also able to growinto macroscopic colonies for use in a non-agarclonogenic assay. In addition, both MT-1 and MaTuformed spheroids and were clonogenic in soft-agar. Thenew lines demonstrated a wide range of sensitivitiesto anticancer agents commonly used in the treatmentof breast cancer, and together with their correspondingxenografts are providing additional systems for the evaluationof new compounds.
Similar content being viewed by others
References
O'Hare MJ: In: Human Cancer in Primary Culture, A Handbook. Kluwer Academic Publications, 1991, pp 271–286
Soule HD, Vazquez J, Long A, Albert S, Brennan M: A human cell line from a pleural effusion derived from a breast carcinoma. J Natl Cancer Inst 51(5): 1409–1413, 1973
Keydar I, Chen L, Karby S, Weiss FR, Delarea J, Radu M, Chaitcik S, Brenner HJ: Establishment and characterization of a cell line of human breast carcinoma origin. Eur J Cancer 15: 659–670, 1979
Engel LW, Young NA, Tralka TS, Lippman ME, O'Brien SJ, Joyce MJ: Establishment and characterization of three new continuous cell lines derived from human breast carcinomas. Cancer Res 38: 3352–3364, 1978
Dickson RB, Lippman ME: Estrogenic regulation of growth and polypeptide growth factor secretion in human breast cancer. Endocrine Rev 8: 29–43, 1987
Nordquist RE, Ishmael DR, Lovig CA, Hyder DM, Hoge AF: The tissue culture and morphology of human breast tumor cell line BOT-2. Cancer Res 35(11): 3100–3105, 1975
Hackett AH, Smith HS, Springer EL, Owens RB, Nelson-Rees WA, Riggs JL, Gardner MB: Two syngenic cell lines from human breast tissue: the aneuploid mammary epithelial (Hs578T) and the diploid myoepithelial (Hs578Bst) cell lines. J Natl Cancer Inst 58(6): 1795–1806, 1977
Meltzer P, Leibovitz A, Dalton W, Villar H, Kute T, Davis J, Nagle R, Trent J: Establishment of two new cell lines derived from human breast carcinomas with HER-2/neu amplification. Br J Cancer 63: 727–735, 1991
Engel LW, Young NA: Human breast carcinoma in continuous culture. Cancer Res 38: 4327–4339, 1978
Naundorf H, Rewasowa EC, Fichtner I, Buttner B, Becker M, Gorlish M: Characterisation of two human mammary carcinomas, MT-1 and MT-3, suitable for in vivo testing of ether lipids and their derivatives. Breast Cancer Res Treat 23: 87–95, 1992
Naundorf H, Fichtner I, Saul GJ, Haensch J, Buttner B: Establishment and characterisation of two new human mammary carcinoma lines serially transplantable in nude mice. 1993, in press
Widmaier R, Wildner GP, Papsdorf G, Graff I: Uber eine Neue, in vitro umbegrenzt wachsende Zellinie, MaTu, von mamma-tumorzellendes Menschen. Arch für Geschwulst-forsch 44: 1–10, 1974
Slater TF, Sawyer B, Strauli U: Studies on succinate-tetrazolium reductase systems III. Points of coupling of four different tetrazolium salts. Biochim Biophys Acta 77: 383–393, 1963
Mosmann T: Rapid colourimetric assay for cellular growth and survival: application to proliferative and cytotoxic assays. J Immunol Methods 65: 55–63, 1983
Alley MC, Scudiero DA, Monks A, Hursey ML, Czerwinski MJ, Fine DL, Abbott BJ, Mayo JG, Shoemaker RH, Boyd MR: Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay. Cancer Res 48(2): 589–601, 1988
Olea-Serrano N, Devleeschhouwer N, Leclercq G, Heuson JC: Assay for estrogen and progesterone receptors of breast cancer cell lines in monolayer culture. Eur J Cancer Clin Oncol 21: 965–968, 1985
Leake RE, Habib F: Steroid hormone receptors: assay and characterization. In: Steroid Hormones: A Practical Approach. IRL Press, Oxford, 1987, pp 67–97
Vickers PJ, Dickson RB, Shoemaker R, Cowan KH: A multidrug-resistant human breast cancer cell line which exhibits cross-resistance to antiestrogens and hormone-independent tumor growth in vivo. Mol Endocrinol 2(10): 886–892, 1988
Lasfargues EY, Ozzello L: Cultivation of human breast carcinomas. J Natl Cancer Inst 21: 1131–1147, 1958
Cailleau R, Mackay B, Young RK, Reeves WJJ: Tissue culture studies on pleural effusions from breast cancer patients. Cancer Res 34: 801–809, 1974
Zoli W, Volpi A, Bonoguri C, Riccobon A, Savini S, Brizio R, Saragoni A, Medri L, Marra GA, Amadori D: An efficient method for culturing human breast carcinoma to evaluate antiblastic drug activity in vitro: experience on 136 primary cancers and 116 recurrences. Breast Cancer Res Treat 17: 231–238, 1990
Amadori D, Bertoni L, Flamigni A, Savini S, Giovanni CD, Casanova S, De Paola F, Amadori A, Giulotto E, Zoli W: Establishment and characterization of a new cell line from primary human breast carcinoma. Breast Cancer Res Treat 28: 251–260, 1993
Smith HS, Wolman SR, Hackett AJ: The biology of breast cancer at the cellular level. Biochim Biophys Acta 738: 103–123, 1984
Ahmed A: Infiltrating ductal carcinoma. In: Atlas of the Structure of Human Breast Disease. Churchill Livingstone, Edinburgh, London & New York, 1978
Calaf G, Abarca-Quinones J, Feuilhade F, Beaune J, Dupre G, Orrico M, Barnabas-Sohi N, Kouyoumdjian JC: New cell lines of breast cancer origin. Breast Cancer Res Treat 21: 63–75, 1992
Carlsson J, Nederman T: Tumour spheroid technology in cancer therapy research. Eur J Cancer Clin Oncol 25(8): 1127–1133, 1989
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hambly, R.J., Double, J.A., Thompson, M.J. et al. Establishment and characterisation of new cell lines from human breast tumours initially established as tumour xenografts in NMRI nude mice. Breast Cancer Res Treat 43, 247–258 (1997). https://doi.org/10.1023/A:1005756632293
Issue Date:
DOI: https://doi.org/10.1023/A:1005756632293